Literature DB >> 8400839

Drug use and cigarette smoking in applicants for drug abuse treatment.

M J Stark1, B K Campbell.   

Abstract

Whereas smoking rates have declined in the last three decades from around 40% to under 30%, the rates for substance abuse clients remain at a plateau almost three times as high. In order to examine the relations between nicotine and drug use, applicants for drug abuse treatment were surveyed about their cigarette smoking. Results indicated that 85% of applicants were smokers. Also, it was found that for smokers, frequency and type of drug use were associated with amount of cigarette use. Among the five categories of primary drugs surveyed, heroin users had the highest levels of smoking. Additionally, frequency of primary drug use and frequency of overall drug use correlated with cigarette smoking. Within categories of primary drug, frequency of use was related to severity of nicotine dependence for marijuana only. Given the possible association between severity of illicit drug use and smoking found in this study, it behooves treatment organizations to help clients overcome their nicotine dependence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8400839     DOI: 10.1016/0899-3289(93)90060-o

Source DB:  PubMed          Journal:  J Subst Abuse        ISSN: 0899-3289


  16 in total

1.  Predictors of Tobacco Use Among New York State Addiction Treatment Patients.

Authors:  Joseph Guydish; Jiang Yu; Thao Le; Anna Pagano; Kevin Delucchi
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

2.  The association between anxiety sensitivity and motivation to quit smoking among women and men in residential substance use treatment.

Authors:  Jennifer Dahne; Elana M Hoffman; Laura MacPherson
Journal:  Subst Use Misuse       Date:  2014-09-29       Impact factor: 2.164

3.  Medical and Mental Health Status Among Drug Dependent Patients Participating in a Smoking Cessation Treatment Study.

Authors:  Jennifer E Lima; Malcolm S Reid; Jennifer L Smith; Yulei Zhang; Huiping Jiang; John Rotrosen; Edward Nunes
Journal:  J Drug Issues       Date:  2009-03

4.  A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).

Authors:  Sandra Nordmann; Caroline Lions; Antoine Vilotitch; Laurent Michel; Marion Mora; Bruno Spire; Gwenaelle Maradan; Alain Morel; Perrine Roux; M Patrizia Carrieri
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

5.  Perceived stress and substance use in methadone-maintained smokers.

Authors:  Ethan Moitra; Bradley J Anderson; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2013-08-26       Impact factor: 4.492

6.  The coupling of nicotine and stimulant craving during treatment for stimulant dependence.

Authors:  Joshua C Magee; Theresa Winhusen
Journal:  J Consult Clin Psychol       Date:  2015-10-12

7.  Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: exploring predictors of outcome as clues toward treatment improvement.

Authors:  Malcolm S Reid; Huiping Jiang; Bryan Fallon; Susan Sonne; Paul Rinaldi; Eva Turrigiano; Cynthia Arfken; James Robinson; John Rotrosen; Edward V Nunes
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

8.  Nicotine dependence and depression among methadone maintenance patients.

Authors:  T J Meyer; M M Lin; L S Brown
Journal:  J Natl Med Assoc       Date:  1996-12       Impact factor: 1.798

9.  Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment.

Authors:  Joseph Guydish; Barbara Tajima; Sowmya Pramod; Thao Le; Noah R Gubner; Barbara Campbell; Paul Roman
Journal:  Drug Alcohol Depend       Date:  2016-07-14       Impact factor: 4.492

10.  Does remission from alcohol and drug use disorders increase the likelihood of smoking cessation among nicotine dependent young adults?

Authors:  Vito Agosti; Frances R Levin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-08-09       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.